|
|
Suppliers for
Iloprost
|
Properties | CAS |
78919-13-8 | Formula |
C22H32O4 |
|
|
14 Registered suppliers
Appearance | White crystalline powder
| Purity | 98% min |
Appearance | White crystalline powder
| Purity | 98% min |
Appearance | White crystalline powder
| Purity | 98% min |
Molecular Formula: C22H32O4 Molecular Weight: 360.49
More details are to be found here
Molecular Formula: C22H32O4 Molecular Weight: 360.49
More details are to be found here
Molecular Formula: C22H32O4 Molecular Weight: 360.49
More details are to be found here
Molecular Formula: C22H32O4 Molecular Weight: 360.49
More details are to be found here
Molecular Formula: C22H32O4 Molecular Weight: 360.49
More details are to be found here
Molecular Formula: C22H32O4 Molecular Weight: 360.49
More details are to be found here
Description : Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. - Molecular Weight :360.49
- Boiling Point :539.2±50.0°C at 760 mmHg
- Purity :98%
Molecular Formula : C22H32O4 Canonical SMILES : CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O InChI : InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1 InChIKey : HIFJCPQKFCZDDL-ACWOEMLNSA-N Solubility : Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) Appearance : Colourless to Pale Yellow Oil to Solid Storage : Store at -20°C under inert atmosphere Synonyms : Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]-, (5E)-; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic acid; Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-ynyl]-2(1H)-pentalenylidene]-, (5E)-; (1S,2R,3R,5S)-7-[(E)-4-Carboxybutylidene]-2-[(3S,1E)-3-hydroxy-4-methyl-6-octyn-1-enyl]-bicyclo[3.3.0]octane; Ciloprost; Endoprost; Ilomedin; ZK 36374
More details are to be found here
Description : Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. - Molecular Weight :360.49
- Boiling Point :539.2±50.0°C at 760 mmHg
- Purity :98%
Molecular Formula : C22H32O4 Canonical SMILES : CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O InChI : InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1 InChIKey : HIFJCPQKFCZDDL-ACWOEMLNSA-N Solubility : Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) Appearance : Colourless to Pale Yellow Oil to Solid Storage : Store at -20°C under inert atmosphere Synonyms : Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]-, (5E)-; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic acid; Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-ynyl]-2(1H)-pentalenylidene]-, (5E)-; (1S,2R,3R,5S)-7-[(E)-4-Carboxybutylidene]-2-[(3S,1E)-3-hydroxy-4-methyl-6-octyn-1-enyl]-bicyclo[3.3.0]octane; Ciloprost; Endoprost; Ilomedin; ZK 36374
More details are to be found here
Description : Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. - Molecular Weight :360.49
- Boiling Point :539.2±50.0°C at 760 mmHg
- Purity :98%
Molecular Formula : C22H32O4 Canonical SMILES : CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O InChI : InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1 InChIKey : HIFJCPQKFCZDDL-ACWOEMLNSA-N Solubility : Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) Appearance : Colourless to Pale Yellow Oil to Solid Storage : Store at -20°C under inert atmosphere Synonyms : Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]-, (5E)-; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic acid; Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-ynyl]-2(1H)-pentalenylidene]-, (5E)-; (1S,2R,3R,5S)-7-[(E)-4-Carboxybutylidene]-2-[(3S,1E)-3-hydroxy-4-methyl-6-octyn-1-enyl]-bicyclo[3.3.0]octane; Ciloprost; Endoprost; Ilomedin; ZK 36374
More details are to be found here
Description : Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. - Molecular Weight :360.49
- Boiling Point :539.2±50.0°C at 760 mmHg
- Purity :98%
Molecular Formula : C22H32O4 Canonical SMILES : CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O InChI : InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1 InChIKey : HIFJCPQKFCZDDL-ACWOEMLNSA-N Solubility : Soluble in Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) Appearance : Colourless to Pale Yellow Oil to Solid Storage : Store at -20°C under inert atmosphere Synonyms : Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]-, (5E)-; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic acid; Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-ynyl]-2(1H)-pentalenylidene]-, (5E)-; (1S,2R,3R,5S)-7-[(E)-4-Carboxybutylidene]-2-[(3S,1E)-3-hydroxy-4-methyl-6-octyn-1-enyl]-bicyclo[3.3.0]octane; Ciloprost; Endoprost; Ilomedin; ZK 36374
More details are to be found here
Detailed information on the suppliers of
Iloprost
|
Properties:
... more properties and specification on Iloprost
|
|
Privileged suppliers
Last update 2024-04-26
|